Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target raised by investment analysts at Scotiabank from $35.00 to $40.00 in a research report issued on Thursday,Benzinga reports. Get Teva Pharmaceutical Industries alerts:Read Our Latest Analysis on Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries Trading Down 0.9%TEVA traded down $0.31 during trading on Thursday, hitting $32.90. Insider Activity at Teva Pharmaceutical IndustriesIn other Teva Pharmaceutical Industries news, insider Mark Sabag sold 216,892 shares of Teva Pharmaceutical Industries stock in a transaction dated Tuesday, December 9th. Guidance / Press ReleaseTeva Pharmaceutical Industries Company Profile(Get Free Report)Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is an Israeli multinational pharmaceutical company and one of the world’s largest manufacturers of generic medicines. Further ReadingReceive News & Ratings for Teva Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.